Glucotrack (GCTK) Capital Expenditures Growth (1y) (2011 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 156.17 Bn | 151.78 Bn | 1.83 Bn | -11.41% |
| 2 | Becton Dickinson | 41.51 Bn | 40.49 Bn | 2.15 Bn | 9.65% |
| 3 | Resmed | 30.43 Bn | 28.77 Bn | 890.98 Mn | 61.83% |
| 4 | West Pharmaceutical Services | 22.78 Bn | 22.26 Bn | 296.40 Mn | -63.39% |
| 5 | Solventum | 13.39 Bn | 13.39 Bn | 1.10 Bn | - |
| 6 | Cooper Companies | 12.33 Bn | 12.20 Bn | 695.20 Mn | 14.32% |
| 7 | Align Technology | 11.65 Bn | 10.59 Bn | 736.59 Mn | 21.73% |
| 8 | Baxter International | 9.81 Bn | 7.77 Bn | 891.00 Mn | 12.30% |
| 9 | Aptargroup | 7.39 Bn | 7.19 Bn | 351.91 Mn | 15.01% |
| 10 | Glucotrack | 290,858.33 | -7.09 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 103.03% |
| Mar 31, 2025 | -84.75% |
| Dec 31, 2022 | -175.00% |
| Dec 31, 2021 | -42.86% |
| Dec 31, 2020 | 1,469.51% |
| Sep 30, 2020 | 145.23% |
| Mar 31, 2020 | 135.18% |
| Dec 31, 2019 | -76.10% |
| Sep 30, 2019 | 693.53% |
| Jun 30, 2019 | 260.35% |
| Mar 31, 2019 | 585.07% |
| Sep 30, 2018 | -89.10% |
| Jun 30, 2018 | -70.91% |
| Mar 31, 2018 | -36.97% |
| Sep 30, 2017 | -49.37% |
| Jun 30, 2017 | -84.97% |
| Mar 31, 2017 | -93.83% |
| Sep 30, 2016 | -61.92% |
| Jun 30, 2016 | 230.66% |
| Mar 31, 2016 | 97.89% |
| Sep 30, 2015 | 2,026.25% |
| Jun 30, 2015 | -82.63% |
| Mar 31, 2015 | 36.72% |
| Sep 30, 2014 | -79.98% |
| Jun 30, 2014 | 17.75% |
| Mar 31, 2014 | 1,026.46% |
| Dec 31, 2013 | 184.95% |
| Sep 30, 2013 | 415.90% |
| Jun 30, 2013 | 1,698.21% |
| Mar 31, 2013 | -52.96% |
| Dec 31, 2012 | 255.65% |
| Sep 30, 2012 | -38.75% |
| Jun 30, 2012 | -95.68% |
| Mar 31, 2012 | -67.03% |
| Dec 31, 2011 | -42.37% |